Application 021948
- Type
- NDA
- Sponsor
- PFIZER
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | ERAXIS | ANIDULAFUNGIN | INJECTABLE; INJECTION | 50MG | No | No |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| ERAXIS | ANIDULAFUNGIN | Roerig | a88d9010-55fb-4a02-baff-042cd27688ea | 2025-08-19 | Warnings, Adverse reactions | ERAXIS ANIDULAFUNGIN |
| ERAXIS | ANIDULAFUNGIN | Roerig | d138ab10-1ed9-44be-8d81-49dda1e434ac | 2024-02-19 | Warnings, Adverse reactions | ERAXIS ANIDULAFUNGIN |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.